Bullfrog AI Holdings, Inc. Common Stock (BFRG) NASDAQ
0.77
+0.0674(+9.59%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.77
+0.0674(+9.59%)
Currency In USD
Address
325 Ellington Blvd.
Gaithersburg, MD 20878
United States of America (the)
Phone
240 658 6710
Website
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Employees
4
First IPO Date
February 13, 2023
| Name | Title | Pay | Year Born |
| Vininder Singh | Founder, Chairman & Chief Executive Officer | 400,347 | 1968 |
| Cetin Savkli | Chief AI Advisor & Member of Advisory Board | 0 | N/A |
| Antonio V. Montano | Chief Marketing Officer & Growth Strategy Leader | 0 | N/A |
| David Recker FACP FACR | Chief Medical Officer | 0 | 1958 |
| Praveen Kudithipudi | Chief Business Development Officer | 0 | N/A |
| J. T. Koffenberger | Chief Information Officer | 0 | N/A |
BullFrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. It offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. The company also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. BullFrog AI Holdings, Inc. was founded in 2017 and is based in Gaithersburg, Maryland.